AXONIS THERAPEUTICS, INC.

formerly Axonis

AXONIS THERAPEUTICS, INC. is a biotech company in Boston, United States, founded in 2020. It has raised $127.5M across 8 rounds, most recently a $115.0M Series A in October 2024.

Reviving Neurons - Restoring Control

Employees
11–50
Founded
2020
Business Model
B2B
Website
axonis.us
Total Funding
$127.5M
Last Round
$115.0M Series AOct 2024
Rounds
8

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 8 funding rounds and 8 investors for this company. The full record is or through the API.

About

Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, a critical mediator of inhibition within the brain. The company translates breakthrough discoveries spun out from Boston Children's Hospital, Harvard, and Laval University into oral therapeutics for currently incurable neurological disorders including pain, epilepsy, and psychiatric conditions. Axonis raised $115M in a Series A round in October 2024 to fund Phase I clinical trials.

Summary

It lists 11–50 employees. It has raised $127.5M in total across 8 rounds, most recently a $115.0M Series A round in Oct 2024. Investors include Cormorant Asset Management, venBIO Partners and Sofinnova Investments.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AOct 2024
$115.0M

Sign up to see all 8 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AXONIS THERAPEUTICS, INC. on Indexed.vc
<a href="https://indexed.vc/companies/axonis-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/axonis-therapeutics-inc" alt="AXONIS THERAPEUTICS, INC. on Indexed.vc" width="260" height="76" /></a>